130 related articles for article (PubMed ID: 11266865)
1. Leflunomide analog, MNA-715, plus cyclosporine reduces renal allograft rejection in mismatched dogs.
Kyles AE; Gregory CR; Griffey SM; Bernsteen L; Jackson J; Morris RE
Transplant Proc; 2001; 33(1-2):368-9. PubMed ID: 11266865
[No Abstract] [Full Text] [Related]
2. An evaluation of combined immunosuppression with MNA 715 and microemulsified cyclosporine on renal allograft rejection in mismatched mongrel dogs.
Kyles AE; Gregory CR; Griffey SM; Jackson J; Bernsteen L; Morris RE
Vet Surg; 2002; 31(4):358-66. PubMed ID: 12094350
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs.
Kyles AE; Gregory CR; Griffey SM; Bernsteen L; Pierce J; Lilja HS; Morris RE
Transplantation; 2003 Apr; 75(8):1128-33. PubMed ID: 12717190
[TBL] [Abstract][Full Text] [Related]
4. Malononitrilamides 715 and 279 prevent accelerated cardiac allograft rejection synergistically with cyclosporin A in presensitized rats.
Qi Z; Simanaitis M; Ekberg H
Transpl Immunol; 1998 Jun; 6(2):94-100. PubMed ID: 9777697
[TBL] [Abstract][Full Text] [Related]
5. Long-term xenograft survival by combination therapy of malononitrilamide MNA 715 with cyclosporine.
Schorlemmer HU; Kurrle R
Transplant Proc; 1997 Dec; 29(8):3501-4. PubMed ID: 9414811
[No Abstract] [Full Text] [Related]
6. Combined immunosuppression with leflunomide and cyclosporine prevents MLR-mismatched renal allograft rejection in a mongrel canine model.
Lirtzman RA; Gregory CR; Levitski RE; Griffey SM; Yeh LS; Patz JD; Morris RE
Transplant Proc; 1996 Apr; 28(2):945-7. PubMed ID: 8623474
[No Abstract] [Full Text] [Related]
7. Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in nonobese diabetic mice.
Gysemans C; Waer M; Laureys J; Bouillon R; Mathieu C
Transplant Proc; 2001 May; 33(3):2094-5. PubMed ID: 11377464
[No Abstract] [Full Text] [Related]
8. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
[TBL] [Abstract][Full Text] [Related]
9. Synergism of the malononitrilamides 279 and 715 with cyclosporine A in the induction of long-term cardiac allograft survival.
Lindner JK; Zantl N
Transpl Int; 1998; 11 Suppl 1():S303-9. PubMed ID: 9665002
[TBL] [Abstract][Full Text] [Related]
10. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides.
Schorlemmer HU; Schwab W; Ruuth E; Kurrle R
Transplant Proc; 1996 Dec; 28(6):3048-50. PubMed ID: 8962182
[No Abstract] [Full Text] [Related]
11. Efficacy of malononitriloamide 279 and 715 in islet xenotransplantation: a study in the pig-to-rat model.
Wijkström M; Song Z; Zhang J; Bari S; Sundberg B; Groth CG; Korsgren O; Wennberg L
Transplant Proc; 2000 Aug; 32(5):1024. PubMed ID: 10936331
[No Abstract] [Full Text] [Related]
12. Malononitrilamides synergistically prevent acute and treat ongoing skin allograft rejection with cyclosporine.
Schorlemmer HU; Ruuth E; Kurrle R
Transpl Int; 1998; 11 Suppl 1():S340-4. PubMed ID: 9665012
[TBL] [Abstract][Full Text] [Related]
13. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
[TBL] [Abstract][Full Text] [Related]
14. Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat.
MacDonald AS; Sabr K; MacAuley MA; McAlister VC; Bitter-Suermann H; Lee T
Transplant Proc; 1994 Dec; 26(6):3244-5. PubMed ID: 7998130
[No Abstract] [Full Text] [Related]
15. Malononitrilamides reduce IgM and IgG xenoantibodies and prolong skin xenograft survival in a mouse-to rat model.
Schorlemmer HU; Kurrle R
Transplant Proc; 1998 Jun; 30(4):976-9. PubMed ID: 9636394
[No Abstract] [Full Text] [Related]
16. A novel leflunomide derivative, FK778, for immunosuppression after kidney transplantation in dogs.
Jin MB; Nakayama M; Ogata T; Fujita M; Mino K; Taniguchi M; Suzuki T; Shimamura T; Furukawa H; Todo S
Surgery; 2002 Jul; 132(1):72-9. PubMed ID: 12110798
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of immunosuppressive efficacy by combining the novel leflunomide analog, HMR 279, with microemulsion cyclosporine in a rat lung transplant model.
Hausen B; Boeke K; Berry GJ; Gummert JF; Christians U; Morris RE
Transplantation; 1999 Feb; 67(3):354-9. PubMed ID: 10030278
[TBL] [Abstract][Full Text] [Related]
18. Triple drug treatment with cyclosporine, leflunomide and mycophenolate mofetil prevents rejection of pig islets transplanted into rats and primates.
Wennberg L; Groth CG; Tibell A; Zhu S; Liu J; Rafael E; Söderlund J; Biberfeld P; Morris RE; Karlsson-Parra A; Korsgren O
Transplant Proc; 1997 Aug; 29(5):2498. PubMed ID: 9270824
[No Abstract] [Full Text] [Related]
19. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of leflunomide in the canine renal transplantation model.
McChesney LP; Xiao F; Sankary HN; Foster PF; Sharma S; Haklin M; Williams JW
Transplantation; 1994 Jun; 57(12):1717-22. PubMed ID: 8016874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
